spec sheet11 rows
Pentobarbital is a short-to-intermediate-acting barbiturate historically used as a sedative, hypnotic, and anesthetic, and today for uses like refractory seizures, controlled coma, and veterinary euthanasia. Barbiturates have a notoriously narrow safety margin; the gap between a sedating dose and a lethal one is small. Combined with alcohol or opioids the overdose risk climbs sharply.
- Strong sedation and hypnosis
- Anesthetic and coma induction in medicine
- Seizure control
- Respiratory depression
- Very narrow safety margin
- Dependence
- Life-threatening withdrawal
Mechanism
Pentobarbital acts at the -A receptor, but differently from benzodiazepines; it binds a distinct site and increases the duration that the chloride channel stays open in response to GABA (the main inhibitory neurotransmitter), and at higher concentrations it can open the channel directly even without GABA. That direct action is why barbiturates have no clear ceiling on their depressant effect, which makes overdose and fatal respiratory depression far easier than with benzodiazepines.
receptor fingerprint
-A receptor (barbiturate site)Positive allosteric modulator; direct agonist at high doses
Safetyrisks and cautions, not medical advice
The core danger is a narrow therapeutic index; a modest overshoot in dose can suppress breathing to a fatal degree, and there's no reliable antidote comparable to naloxone for opioids. Mixing with alcohol, opioids, or other sedatives is extremely dangerous. Barbiturates cause tolerance and dependence, and withdrawal can be life-threatening with seizures. Not medical advice.
Interactionsdocumented pairs only, not exhaustive
Two mechanisms account for nearly all of it. The first is additive central nervous system depression: with opioids, benzodiazepines, alcohol, sedating antihistamines or general anesthetics, respiratory depression and loss of airway reflexes are the danger, and barbiturates have a narrower margin than benzodiazepines because no equivalent of flumazenil exists to reverse them.
The second is enzyme induction. Pentobarbital induces CYP3A4, CYP2C9, CYP1A2 and glucuronidation, lowering exposure to warfarin, hormonal contraceptives, corticosteroids, doxycycline, protease inhibitors, ciclosporin and several antiepileptics; contraceptive failure is a documented consequence. Induction builds over one to two weeks and takes a similar time to fade once the barbiturate stops, so the loss of it can then push those same drugs into toxicity.
Barbiturates also induce delta-aminolevulinic acid synthase and can precipitate an attack in acute intermittent porphyria.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
A serious hospital drug and nothing else. The gap between a sedating dose and a fatal one is small, there is no naloxone equivalent to reverse it, and withdrawal can itself be life-threatening; alcohol or opioids alongside it close that gap further.
Resources
This entry is here for reference.
Research
- 1.Self-administered pentobarbitone overdose with prolonged coma and delayed toxicological diagnosis
- 2.Trends in CNS affecting drugs in the calls to the Toxicological Information Center from 1997 to 2012
2 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
Why are barbiturates more dangerous than benzodiazepines?
At higher doses they can open the GABA-A chloride channel directly, with no ceiling effect, so overdose and fatal respiratory depression come far more easily.
Is there an antidote?
No, there is no reliable reversal agent like naloxone; overdose care is supportive with breathing and circulation support.
Is withdrawal dangerous?
Yes. Barbiturate withdrawal can be life-threatening, including seizures, and requires medical supervision.
Adverse effects
- Respiratory depression
- Very narrow safety margin
- Dependence
- Life-threatening withdrawal